WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vir Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Verneuil Vanina DeEVP General Counsel Corp Sec2025-11-052,385$5.16
$12.31kSell
Verneuil Vanina DeEVP and General Counsel2025-11-031,365$5.86
$8.00kSell
Vicki L. SatoDirector2025-11-0322,000$5.64
$124.04kSell
Svf Endurance Cayman Ltd10% Owner2025-10-29100$6.49
$649.00Sell
Svf Endurance Cayman Ltd10% Owner2025-10-2824,453$6.50
$159.02kSell
Svf Endurance Cayman Ltd10% Owner2025-10-2766,403$6.05
$401.61kSell
Svf Endurance Cayman Ltd10% Owner2025-10-2446,696$5.96
$278.31kSell
Svf Endurance Cayman Ltd10% Owner2025-10-23154,383$5.99
$924.75kSell
Svf Endurance Cayman Ltd10% Owner2025-10-22144,266$6.15
$887.67kSell
Svf Endurance Cayman Ltd10% Owner2025-10-21109,675$6.30
$690.95kSell

1 of 4

VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIR insiders and whales buy or sell their stock.

VIR Shareholders

What type of owners hold Vir Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sb Investment Advisers Uk Ltd11.99%16,684,041$85.42MInstitution
Alaska Permanent Fund Corp11.98%16,666,668$85.33MInsider
Blackrock Inc11.61%16,153,190$82.70MInstitution
Svf Endurance Cayman Ltd10.48%14,573,983$74.62MInsider
Vanguard Group Inc9.51%13,227,066$67.72MInstitution
Arch Venture Management LLC9.28%12,916,663$66.13MInstitution
Temasek Holdings Private Ltd3.95%5,499,999$28.16MInsider
State Street Corp3.78%5,254,712$26.90MInstitution
Dhabi Investment Authority Abu2.64%3,666,666$18.77MInsider
Fmr LLC2.56%3,558,655$18.22MInstitution

1 of 3

VIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIR67.90%32.10%Net SellingNet Selling
GYRE2.05%97.95%Net Buying
VALN2.78%0.00%
ATXS80.69%19.31%
CRMD50.35%10.12%Net SellingNet Buying
View Top Biotech Stocks

Vir Biotechnology Stock Ownership FAQ

Who owns Vir Biotechnology?

Vir Biotechnology (NASDAQ: VIR) is owned by 79.67% institutional shareholders, 37.66% Vir Biotechnology insiders, and 0.00% retail investors. Alaska Permanent Fund Corp is the largest individual Vir Biotechnology shareholder, owning 16.67M shares representing 11.98% of the company. Alaska Permanent Fund Corp's Vir Biotechnology shares are currently valued at $85.33M.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.